Zyprexa Pulls Down Lilly's 4Q SalesRevenues were hurt by reduced sales of Eli Lilly's lead product Zyprexa (a treatment for schizophrenia and bipolar disorder). Sales of Zyprexa, which went off patent in the EU and the US in late 2011, plummeted 44% in the ... |
Eli Lilly results hammered by Zyprexa patent loss - Pharmaceutical ...US drug major Eli Lilly (NYSE: LLY) said that fourth-quarter 2011 global sales dropped 2% to $6.05 billion. This fall in revenue was comprised of an 11% decline due to price, partially offset by an increase of 8% in volume and ... |
NewsDaily: Eli Lilly profit drops sharply on Zyprexa genericsEli Lilly & Co's quarterly profit dropped 27 percent after its top-selling Zyprexa schizophrenia treatment lost U.S. patent protection and saw competition from generic rivals. |
Dr. Reddy's Going StrongGrowth was mainly driven by the launch of a generic version of Eli Lilly & Co.'s (NYSE:LLY) Zyprexa (olanzapine) 20 mg. Dr. Reddy's currently has 180-day marketing exclusivity for the generic drug. Since generic Zyprexa ... |
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly ...Growth was mainly driven by the launch of a generic version of Eli Lilly & Co.'s ( LLY) Zyprexa (olanzapine) 20 mg. Dr. Reddy's currently has 180-day marketing exclusivity for the generic drug. Since generic Zyprexa was ... |
Article > Lilly earnings hit hard as Zyprexa loses patentEli Lilly has posted a 27% decline in earnings for the fourth quarter, but sales dipped only 2%, despite the US patent expiry on antipsychotic Zyprexa and thanks again to the performances of the antidepressant/fibromyalgia ... |
Switching to generic Lipitor - Harvard Health PublicationsI was a patient back in 1996-2000 who was a subject of Eli Lilly's Zyprexa 'viva' Zyprexa' off label sales promotion.I was given it as an ineffective costly treatment for PTSD It gave me diabetes as a side effect.–Daniel Haszard ... |
Eli Lilly Up After Besting 4Q Expectations - Stocks To Watch Today ...I was a patient back in 1996-2000 who was a subject of Eli Lilly's Zyprexa 'viva' Zyprexa' off label sales promotion.I was given it as an ineffective costly treatment for PTSD It gave me diabetes as a side effect.–Daniel Haszard ... |
Pharmaceutical Field - Revenue up but income down at LillyGlobal revenue increased 5% in 2011 at Eli Lilly to $24.2 billion after the company saw demand increase but net income fall 14% to $4.3bn. Agreements to supply generic versions of Zyprexa and Gemzar helped reduce the impact after the two ... |
